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Abstract
Background: The aim of this study was to examine the Tpeak-Tend (Tpe/corrected Tpe) interval, which is an
indicator of transmural myocardial repolarization, measured non-invasively via electrocardiogram in patients with acute
pulmonary embolism (PE), and to investigate the relationship with 30-day mortality and morbidity.
Methods: The study included 272 patients diagnosed with acute PE, comprising 154 females and 118 males,
with a mean age of 63.1 ± 16.8 years. Tpe/cTpe intervals were calculated from the electrocardiograms with a computer
program after using a ruler or vernier caliper manual measuring tool to obtain highly sensitive measurements.
The relationship between the electrocardiogram values and 30-days mortality and morbidity were measured.
Results: The study group was divided into three groups according to cTpe intervals: Group 1, < 113 ms; Group 2,
113–133 ms; and Group 3, > 133 ms. White blood cell count and troponin T levels, corrected QT intervals with QRS
complex durations, percentage of right ventricle dilatation with right/left-ventricular ratio, 30-day death, and
combinations of these values were seen at a higher rate in Group 3 patients compared to the other groups.
Kaplan–Meier analysis showed that the cTpe interval measured at > 126 ms could be used as a cut-off value
in the prediction of mortality and morbidity. The cTpe cut-off values of 126 ms had sensivity, specificity, negative
predictive value, and positive predictive value of 80.56 %, 59.32 %, 95.2 %, and 23.2 %, respectively.
Conclusions: cTpe interval could be a useful method in early risk stratification in patients with acute PE.
Background
Despite the development of several diagnostic and treat-
ment methods for acute pulmonary embolism acute (PE),
the condition continues to be a significant cause of cardio-
vascular morbidity and mortality [1, 2]. According to
current guideline recommendations, risk stratification
of patients with acute PE is mandatory to allow assess-
ment of the individual prognosis and to guide therapeutic
decision making. As a result, various combinations of
clinical findings with imaging and laboratory tests have
been proposed and tested in registries and cohort studies
in an attempt to improve risk stratification [3, 4]. Electro-
cardiogram (ECG) is used less in acute PE diagnosis due
to the existence of newer diagnostic modalities, such as
echocardiography, computed tomography, and angiog-
raphy [5–7]. The value of ECG has not declined, however,
as it is easily conducted, non-invasive, and inexpensive.
ECG used in the setting of acute PE patients may present
a wide variety of manifestations. Several ECG markers of
ventricular repolarization have been reported to identify
high-risk patients with acute PE [8]. The mechanism for
the appearance of ventricular repolarization following the
onset of acute PE is unknown, but may involve the devel-
opment of acute cor pulmonale caused by the enlargement
of the right ventricle (RV) due to rapid RV pressure over-
load [9, 10]. In acute PE patients, a sudden increase in RV
arterial load leads to reduced cardiac output by impairing
left ventricle (LV) circulation, and can lead to evident
impairment of coronary perfusion and RV damage
[11, 12]. The increase in RV pressure and volume
leads to greater wall tension and myocyte stretch; RV
contraction time is prolonged, while neurohumoral
activation leads to inotropic and chronotropic stimulation
[13]. In addition, severe RV ischemia may alter the path-
way of electrical repolarization, resulting in inverted T
waves [14]. acute PE affects both the circulation and gas
exchange. The primary cause of death in severe PE is the
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result of right ventricular failure due to pressure overload.
The prolongation of RV contraction time into early
diastole in the LV leads to leftward deviation of the inter-
ventricular septum. As a result, LV filling is hindered in
early diastole, which may lead to a reduction of the cardiac
output and contribute to systemic hypotension and
hemodynamic instability. In addition, excessive neurohu-
moral activation in acute PE can be the result both of
abnormal RV wall tension and of circulatory shock [15].
Therefore, the differences in the repolarization of ven-
tricular myocardial consist of course of time (just as in
various cardiac diseases, such as the Brugada, short QT,
and long QT syndromes) and catecholaminergic poly-
morphic ventricular tachycardia. Differences in the time-
course of the repolarization of these three predominant
ventricular myocardial cell types contribute significantly to
T-wave morphology. These differences in action potential
morphology lead to the development of opposing voltage
gradients on either side of the subendocardial (M cell)
region, which contributes to the inscription of the T wave:
especially those that are inscribed in the precordial lead
V5 [16]. Measuring the interval between the peak and the
end of the T wave (Tpe) as an index of transmural disper-
sion of repolarization is a parameter that is thought to be
capable of reflecting the dispersion of repolarization, and
thus may be used as a prognostic tool for the detection of
arrhythmic risk [17].
In this study, we discuss the potential value of Tpe as
an index of transmural dispersion of repolarization in
patients with acute PE. Prolonged Tpe has been associated
with increased risk of mortality in the congenital and
acquired long QT syndromes [18] and hypertrophic
cardiomyopathy [19], as well as in patients who are under-
going primary percutaneous coronary intervention for
myocardial infarction [20]. Information is lacking, how-
ever, about assessing Tpe in patients with acute PE. The
aim of this study was thus to investigate the predictive
value of Tpe/cTpe, measured via ECG in patients with
acute PE, for 30-day morbidity and mortality.
Methods
Study population
This retrospective study included adult patients who had
been diagnosed with acute PE who were treated at our
university hospital between January 2010 and June 2014.
Of the 340 patients, 300 were confirmed as having PE by
pulmonary computed tomography, 22 by ventilation/
perfusion scintigraphy, and 18 by transthoracic echocardi-
ography. The study was approved by Ethics Committee of
Necmettin Erbakan University Clinical Investigations
(date/approval number: 2015.01.16/104). The study was
conducted in accordance with the ethical principles de-
scribed by the Declaration of Helsinki.
Exclusion criteria
Patients were excluded if their ECG was unsuitable for
analysis, or if the admission records indicated left bundle
branch block or had incomplete echocardiograhy data.
Patients with hematological disorders (white blood
cell < 3.0–109/L or > 20.0–109/L), infectious or inflamma-
tory diseases, or serious renal or liver disease, as well as
those currently using immunosuppressant drugs (in-
cluding steroids), were excluded from the study. After
the exclusion of 68 patients who had PE, 272 patients
were found to be eligible for the study (Fig. 1).
Study protocol
Acute PE cases were screened by ICD-9 code I26 from
the hospital’s electronic database. After the initial screening
process, the PE diagnostic methods of computed tomog-
raphy, scintigraphy, or echocardiography were determined,
and patients were classified into “definitive acute PE” or
“suspicion of acute PE” groups. Suspicious cases were
excluded from the analysis. The exclusion criteria were
examined in the definitive acute PE group (Fig. 1). Patients
who could not be contacted following discharge were
excluded. All patients (or their respective relatives) were
contacted via telephone and were questioned about 30-
day mortality. The study included 272 patients with inter-
pretable ECG recordings, and for whom the prognostic
follow-up could be applied for 30 days. The patients com-
prised 154 females and 118 males, with a mean age of
63.1 ± 16.8 years. Of the 68 patients excluded from the
study, 26 had incomplete echocardiography, 8 did not
undergo echocardiography, 8 had left brach bundle block
in the ECG, 20 had excessive “noise” in the ECG, and 10
had missing laboratory data (Fig. 1).
The digital patient record system was examined in
detail for all patients, and a record was made of baseline
characteristics (sex, age, etc.), comorbidities, symptoms,
hemodynamic conditions, 30-day mortality rates during
hospitalization, total hospitalization period, radiographic
test results, and laboratory findings. The ECGs and
echocardiography taken upon admission were evaluated
(Table 1). Geneva and Wells scores were retrospectively
assessed for all patients.abc means that statitically signifi-
cant differece between subgroups as a: group1 vs. 2, b:
group 1 vs 3, c: group 2 vs. 3.
Echocardiographic evaluation
Transthoracic echocardiography recordings were obtained
from the patients’ records. If a patient’s echocardiography
data included all of the required measurements (RV/LV
diameters, ejection fraction, or pulmonary artery pressure),
the data was defined as complete; otherwise, it was defined
as incomplete. In this study, we used the recorded data
from comprehensive echocardiograhy performed upon
admission on subjects in the left lateral decubitus position.
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To calculate the RV/LV ratio, archived measurements
were used from the mid-cavitary end-diastolic diameters
recorded from the standard, apical four-chamber view.
In addition, archived data were used of pulmonary
artery systolic pressure, which was derived as the sum
of the tricuspid regurgitant gradient, obtained from
continuous-wave Doppler.
Definition of adverse clinical events
Our statistical analysis focused on the 30-day period. The
adverse clinical events were overall mortality and a com-
plicated course, defined as death or one of the following:
the need for catecholamine blood pressure support, car-
diopulmonary resuscitation (noninvasive positive pressure
ventilation or invasive positive pressure ventilation), or
mechanical cardiovascular support due to hemodynamic
instability. “Hemodynamic instability” was defined as: (1)
PE causing hypotension (systolic blood pressure ≤ 90 mm
Hg, or a reduction of at least 40 mm Hg for at least
15 min); (2) tachycardia (pulse rate ≥ 110/min); (3) hypox-
emia (PaO2 < 60 mmHg); (4) blurred consciousness; or (5)
syncope associated with hypotension, oliguria, or cool
extremities. “Shock index” was defined as the ratio of the
systolic blood pressure heart rate.
Measurement of Tpe, cTpe, QT, cQT, and QRS intervals
from the 12-Lead ECG
An “appropriate” ECG was defined as one that had at least
ten analyzable leads for the required measurements.
Otherwise, the ECG was considered to be excessively
noisy. ECG measurements were conducted from ECG re-
corded upon admission using a supine, standard 12-lead
ECG tracing at 25 mm/s paper speed at 10 mm/mV
amplitude. All ECG recordings were screened through
a computer at 800-dpi resolution. The Tpe/cTpe in-
tervals were calculated with a computer program after
using a ruler or vernier caliper manual measuring
tool to obtain highly sensitive measurements (Fig. 2).
Tpe and QT intervals were measured in lead V5. If
V5 was not suitable, leads V4 or V6 (in that order)
were measured [21]. The end of the T wave was de-
fined as the intersection of the tangent to the down-
slope of the T wave and the isoelectric line (when
not followed by a U wave or if distinct from the fol-
lowing U wave). If a U wave followed the T wave, the T
wave offset was measured as the nadir between the T and
U waves. If the T wave amplitude was <1.5 mm in a par-
ticular lead, that lead was excluded from the analysis. The
QT interval was measured from the earliest onset of the
340 patients screened 
with ICD-9 code I26
excluded 68 patients who can not be 
confirmed diagnosis of pulmonary 
embolism
Patients excluded from the study;
*Reference ECG recordings no or 
inadequate ones,
   * LBBB, 
   *with hematologic disease (WBC 
<3X109 / L, WBC> 20.0X109L, PLT 
<105000, HGB <8 mg / dL),
   * with infectious and inflammatory 
diseases
   * with severe renal and hepatic 
failure,
* patients who died acute coronary 
syndrome, cerebrovascular disease 
and malignancy
* unsuccessful contact patients 
340 patients who definitive diagnosis 
was confirmed by
* Pulmonary computed tomography
* Ventilation / perfusion 
scintigraphy
* Echocardiography
272 patients were included 30-day mortality follow-up
Fig. 1 Flow chart of the study design. WBC:white blood cell count; PLT: platelet count; HGB: haemoglobin
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QRS complex (so-named for the Q, R, and S waves in an
ECG) to the end of the T wave. In patients with atrial fib-
rillation and flutter, Tpe was measured in five consecutive
beats. All measured intervals were corrected according to
the Bazzet formula, which considers heart rate. Patients
were divided into three groups based on the tertile of cor-
rected Tpeak-Tend. The lowest tertile included patients
whose Tpe/cTpe values ranged from 80–113 ms, the mid-
dle tertile ranged from 113–133 ms, and the highest tertile
ranged from 134–188 ms.
All ECG measurements were performed by two in-
dependent cardiologists who were blinded to other
patient information. To estimate intra-observer and
inter-observer variability, twenty randomized ECGs
were re-analyzed, and the measurements were re-
peated by two cardiologists. To assess inter-observer
variation, all ECG tracings were analyzed by a second,
independent investigator who was blinded to the re-
sults obtained by the first investigator.
Statistical analyses
The data were analyzed using SPSS software version
18.0 (SPSS, Chicago, IL, USA) and were presented as
mean ± standard deviation. The distribution of the vari-
ables was analyzed with the Kolmogorov–Smirnov test.
Correlation analysis was carried out with the Spearman
correlation test for non-parametrically distributed vari-
ables. The differences between the three groups were
tested via independent Student’s t-tests for normally dis-
tributed variables; the Mann–Whitney U test was used for
non-parametrically distributed variables. The differences
between the categorical variables were determined by the
chi-squared test. The Kaplan–Meier survival analysis was
performed to compare the difference of survival between
Table 1 Demographic, clinical and laboratory characteristics of all groups
Variables Group 1, (n = 87) Group 2, (n = 93) Group 3, (n = 92) P
Demographic features
Age.years 58.7 ± 17.7*a.b.c 63.8 ± 16.0 66.13 ± 16.00 0.01
Gender (Male/Female 45/42 54/39 54/38 0.58
Malignancy. n (%) 14 (16.1) 24 (25.8) 18 (19.6) 0.26
CAD n (%) 9 (10.3) 16 (17.4) 23 (25) 0.04
Hypertension. n (%) 26 (30.2) 30 (32.3) 40 (43.5) 0.13
DiabetesMellitus. n (%) 12 (13.8) 16 (17.2) 23 (25) 0.14
HemodynamicParameters
SystolicBp (mmHg) 112.1 ± 18.5 113.0 ± 21.7 109.6 ± 23.7 0.56
DiastolicBp (mmHg) 70.4 ± 10.8 69.9 ± 12.2 70.8 ± 14,0 0.96
Heart Rate (bpm) 87.5 ± 21 107.4 ± 115 118.2 ± 145,2 0.20
O2 saturation (%) 87.3 ± 17.3 87.1 ± 8.5 86.8 ± 15.6 0.98
SHOCK index 0.8 ± 0.2 1,0 ± 0.1 1.1 ± 1.3 0.11
Laboratory Findings
WBC 9.5 ± 3.6 10.7 ± 4.7 12.77 ± 6.3 0.0001
Haemoglobin (g/dL) 14.1 ± 15.5 11.7 ± 2.3 12.5 ± 8.9 0.14
TroponinT mg/dL, median (IQR) 0.11(0.17)a 0.12(0.24) 0.23(0.48) 0.03
Clinical scores
Genevascore 8,8 + 12,5 7,8 + 3,5 7,3 + 3,4 0,44
Wellsscore 5,5 + 2,0 5,4 + 2,0 5,2 + 1,6 0,69
Echocardiographic measurements
RV dilatation (%) 27 (50.9) 30 (68.2) 38 (74.5) 0.04
EF 59.0 ± 7.5 57.7 ± 7.5 58.6 ± 6.1 0.64
PAB 52.6 ± 21.4 57.1 ± 16.3 54.9 ± 18.3 0.45
RVLV ratio 1,03 ± 0,16 1,16 ± 0,20 1,28 ± 0,23 0.001
clinical outcome for 30 days
Death 2 (2.3) 10 (10.8) 24 (26.1) 0.001
Combine endpoint 3 (3,5)*a 14 (15,1) 25 (27,5) 0,001
*abc means that statitically significant differece between subgroups as a: group1 vs. 2, b: group 1 vs 3, c: group 2 vs. 3
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above- and below-median cTpe values, as well as the
differences among cTpe tertiles using log-rank tests.
Results
Of the 68 patients excluded from the study, 26 had in-
complete echocardiography, 8 did not undergo echocar-
diography, 8 had left brach bundle block in the ECG, 20
had excessive noise in the ECG, and 10 had missing la-
boratory data. The demographic, clinical, and laboratory
characteristics of the three groups are presented in
Table 1. The mean ages of the patients in the groups
were 58.7 ± 17.7, 63.8 ± 16.0, and 66.13 ± 16.0 y, respect-
ively. The total study population comprised 119 females
(44 %) and 153 males (56 %). There were significant
differences between the three groups in age, coronary
artery disease, white blood cell, troponin T, thrombolytic
therapy, Qanadli score, RV/LV ratio, death, and com-
bined endpoint (the need for NPPV, IPPV, and/or
hemodynamic support) (p < 0.05). The Geneva and Wells
scores were similar in the three groups. Seventy-two pa-
tients (26.5 %) were administered thrombolytics due to a
diagnosis of high-risk PE (tissue plasminogen activator
in nine patients, and streptokinase in sixty). Of the 359
initially included patients, thirty-six (13.2 %) died within
one month of diagnosis. Of those, ten (27.7 %) were
administered a thrombolytic drug, and two died due to
major bleeding as a complication of thrombolytic appli-
cation. Thirty deaths occurred in the hospital, and six
following discharge. A significantly higher number of pa-
tients in Group 3 were treated with thrombolytic therapy
compared to the other groups (Table 2).
The echocardiographic data were compared between the
groups, with no difference determined in ejection fraction
and pulmonary artery systolic pressure (p = 0.64, p = 0.45,
respectively). There was a significant difference between
the groups in RV dilatation and RV/LV ratio (p = 0.04); this
statistically significant difference was significantly higher in
Group 3 than in the other groups (Table 1).
The electrocardiographic findings of the three groups
upon admission were compared, and no differences were
determined in the ECG findings of left axis deviation, ST-
segment depression, low voltage, findings of RV
hypertrophy, or heart rate (Table 1). The median value of
the cTpe was 113 ms. There was a significant difference
between the groups in Tpe tangent (ms) (p = 0.001), cor-
rected Tpe (ms) (p = 0.001), cQT interval (msn) (p = 0.001),
Tpe/QT, QRS duration (msn) (p = 0.001), and negative T
score (n) (p = 0.001). These differences were significantly
higher in Group 3 compared to the other groups (Table 1).
In terms of adverse 30-day clinical events, there were
significant differences between the groups in combined
endpoint and death. Death and combined endpoint (the
need for NPPV, IPPV, and/or hemodynamic support)
were significantly higher in Group 3 compared to the
other groups (Table 1). The optimal cTpe cut-off value
for 30-day mortality was determined at 126 ms with re-
ceiver operating characteristic analysis. The cTpe cut-off
value of 126 ms had sensitivity of 80.56 %, specificity of
59.32 %, negative predictive value of 95.2 %, and positive
predictive value of 23.2 % (Fig. 3). Patients with cTpe >
126 ms had a significantly lower 30-day survival rate on
the Kaplan-Meier curve. When the whole study popula-
tion was stratified into cTpe tertiles, the survival curve
of the third tertile was significantly lower than that of
the other tertiles (Fig. 4).
The univariate logistic regression analyses for the predic-
tors of all-cause mortality in the study group are presented
in Table 3. The logistic regression analyses showed signifi-
cant effects in the following parameters on 30-day death
rates: age, ejection fraction, shock index, troponin T, white
blood cell , thrombolytic therapy, and cTpe. When cTpe >
126 ms was added into the same regression model (while
the independent predictors remained unchanged), the
hazard ratio (HR) for cTpe significantly increased (HR: 12.9
[3.05–54.65, CI 95 %] p = 0.001). In the latter model, other
independent predictors were age (HR: 1.03 [1.00–1.05,
CI 95 %] p = 0. 007), shock index (HR: 25.40 [6.51–
99.13, CI 95 %] p = 0.0001), troponin T (HR: 1.08
[1.01–1.15, CI 95 %] p = 0.01), white blood cell (HR: 1.11
[1.06–1.17, CI 95 %] p = 0.007), thrombolytic therapy (HR:
2.42 [1.25–4.68, CI 95 %] p = 0.001), and EF (HR: 0.94
[0.90–0.98, CI 95 %] p = 0. 005) (Table 3).
In linear relationships, the cTpe interval showed a
positive correlation with heart rate, white blood cell,
troponin T, RV/LV ratio, and negative T score (Table 4).
Discussion
The present study demonstrated the prognostic value of
Tpe upon hospital admission in patients with acute PE. To
the best of our knowledge, little is known about the use of
Tpe for identifying risk in patients with acute PE. A stand-
ard 12-lead ECG is especially useful in the differentiation
of acute PE from acute coronary syndrome. Although the
S1Q3T3 pattern is specific to acute PE, it is a frequently
encountered pattern, which renders its diagnostic value
debatable [22]. Right bundle branch block, P pulmonale,









Tp-e tangent (ms) 96.5 + 6.6 95.7 + 7.7 110.0 + 10.0 0.001
Corrected Tp-e (ms) 101.4 + 8.2 123.6 + 5.7 151.8 + 14.0 0.001
cQT interval (msn) 85.2 ± 9.2 94.6 ± 9.8 109.2 ± 11.4 0.001
Tp-e/QT 0.22 ± 0.04 0.24 ± 0.05 0.29 ± 0.07 0.001
QRS duration (msn) 14.9 ± 1.6 15.6 ± 1.6 16.6 ± 1.7 0.001
Neg T score (n) 0.9 + 1.5 2.2 + 2.0 3.8 + 2.2 0.001
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supraventricular and ventricular arrhythmias, reduced QRS
amplitude, ST-segment depression, and abnormalities of
cardiac repolarization (such as T-wave abnormalities) are
also commonly encountered [23–25]. Vanni et al. reported
that the commonly seen RV strain pattern (Right Branch
Bundle Block, T negativity in precordial derivations,
S1Q3T3) could predict short-term prognosis independent
of normal blood pressure and echocardiograph abnormal-
ities [26].
The most extensive study on this phenomenon was con-
ducted by Kosuge et al., who found a relationship between
the number of negative T waves seen in 12-lead ECG and
the severity of acute PE, confirmed via computed
tomography angiography and echocardiography. They
also showed that the number of negative T waves
during the course of hospitalization was the most signifi-
cant predictor of death, and inotropic and mechanical
cardiovascular support were secondary to hemodynamic
instability [9]. Our study’s results were consistent with
these works in terms of negative T scores. In another
study, of 42 patients, Ding et al. showed an increase
in QT and cQT dispersion calculated in the first 24 h
in acute PE patients. Together with RV dysfunction,
the authors reported increased cQT dispersion to be
an indicator of poor prognosis [27]. Ryu et al. exam-
ined various ECG patterns seen in acute PE patients.
They demonstrated that reverse T waves in V1–4
derivations and sinus tachycardia could be used in
risk stratification [8].
The Tpe interval has been proposed as a more repre-
sentative measure of the repolarization, because it is
less dependent on heart rate, autonomic modulations,
and QRS duration than the QT and QTp intervals
Fig. 2 measurement of Tp-e via the tangent method with a computer program
Fig. 3 Optimal cTp-e cutoff value for 30-day mortality was determined
as 126 ms with ROC analysis. cTp-e cutoff value of 126 ms had sensivity,
specificity, negative predictive value and positive predictive value of
80,56 %, 59,32 %, 95,2 % and 23,2 %, respectively
Fig. 4 Patients with cTp-e > 126 ms had significantly lower 30-day
survival rate in Kaplan- Meier curve (Fig. 4). We stratified the whole
study population into cTp-e tertiles and suvival curve of the three
tertile was significantly lower compared with other tertiles
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[28]. Increased Tpe interval might be a useful index
to predict ventricular tachyarrhythmias and cardio-
vascular mortality [29]. Previous studies have shown
that prolongation of the Tpe interval is associated
with increased mortality in patients with Brugada syn-
drome, long QT syndrome, atrioventricular nodal re-
entrant tachycardia, hypertrophic cardiomyopathy, and
ST-segment elevation myocardial infarction [30, 31].
Our study concludes that there is a direct association
between prolonged Tpe interval and increased fatal events
in Group 3 patients when compared to the other two
groups. To answer the question of what the optimal pro-
longed Tpe value is, we can answer that in healthy
individuals, the mean Tpe interval is approximately 86
milliseconds in the left chest leads, similar to what others
have previously reported [32].
Tpe values >100 ms during acute myocardial in-
farction [20] and > 113 ms in the setting of acquired
bradyarrhythmias [18] have been reported previously in
the literature as being “high risk”. Tatlisu et al. conducted
a study in which they found that a cTpe interval of more
than 114 ms was considered risky [33]. We found that
patients in Group 3 had a prolonged Tpe interval, with a
value of 110.0 ± 10.0 ms (versus 96.5 ± 6.6 ms in Group 1).
In the current study, the patients with prolonged Tpe/
cTpe intervals had higher clinical scores and worse white
blood cell values and echocardiography results. In addition,
the rates of 30-day death and combined endpoints in
Group 3 were higher in these patients than in the other
groups. Regression analysis showed that the cTpe interval
obtained in the first 24 h in acute PE patients could predict
in-hospital mortality and combined endpoints. In addition,
more patients with long Tpe intervals were older and fe-
male, which may show that patient groups with this profile
are at greater risk. Panikkath et al. recently showed that the
Tpe/QT ratio is a more accurate measurement of ventricu-
lar repolarization than QT, cQT, and Tpe durations, and is
independent of heart rate [34]. In the current study, the
cQT and Tpe/QT ratios of patients with prolonged cTpe
intervals were high, which was consistent with the dura-
tions found in Panikkath et al.’s study. Increased cTpe in-
tervals were associated with higher likelihood of in-hospital
death and combined clinical endpoints. In addition, a
Kaplan–Meier analysis showed that patients with cTpe that
was longer than 126 ms more frequently reached in-
hospital mortality and combined clinical endpoints.
Conclusion
In conclusion, prolonged cTpe shows potential as a prog-
nostic tool in early risk stratification in patients with acute
PE. Future prospective studies and randomized controlled
trials are warranted to validate these findings and to estab-
lish standardized cut-off values for cTpe.
Study limitations
The primary limitations of this study are that it was
retrospective, observational, and single-center, and that
it examined a limited number of patients in a specific
period (as such, a longer follow-up period could not be
applied). It may have been useful to apply arrhythmia
analysis to these patients, with Holter monitor follow-up.
Another limitation may be that qualitative and/or quanti-
tative measurement could not be applied to the RV.
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Table 3 Regression analyses for the predictors of all- cause
mortality in the study population
Variables Regression analysis
OR (95 % CI) p
Age 1,03 (1,00-1,05) 0,007
EF 0,94 (0,90-0,98) 0,005
SHOCK index 25,40 (6,51- 99,13) 0,0001
ThrombolyticTherapy n (%) 2,42 (1,25- 4,68) 0,008
WBC 1,11 (1,06-1,17) 0,0001
Troponin T 1,08 (1,01- 1,15) 0,01
cTp-e 12,9 (3,05- 54,65 ) 0,001
RVLV ratio 0,82 (0,12- 5,32) 0,83
Gender 0,82 (0,41- 1,60) 0,56
DM 1,76 (0,85-3,65) 0,12
RV dilatation (%) 1,90 (0,52-6,92) 0,32
CAD 1,58 (0,74- 3,37) 0,23
Table 4 Linear association between Tp-e, c Tp-e values and
other variables
Variables T p-e tangent (ms) cT p-e tangent (ms)
R p r p
Systolic Bp (mmHg) −0,48 0,45 −0,92 0,15
Diastolic Bp (mmHg) −0,41 0,52 −0,41 0,52
Heart Rate (bpm) 0,05 0,43 0,19 0,003
O2 saturation(%) 0,18 0,85 −0,46 0,62
SHOCK index 0,5 0,17 0,01 0,5
RVLV ratio 0,44 0,0001 0,42 0,0001
WBC 0,17 0,005 0,23 0,0001
TroponinT 0,19 0,03 0,21 0,01
EF −0,10 0,22 −0,09 0,23
Neg T score 0,60 0,0001 0,55 0,0001
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